4.3.2.2	2'-deoxy-AMP	-	12291	
4.3.2.2	2'-deoxy-AMP	competitive	12291	
4.3.2.2	4-aminopyrazolo[3,4-d]pyrimidine ribose 5'-phosphate	-	45195	
4.3.2.2	5-aminoimidazole-4-carboxamide ribonucleoside	50% inhibition at 0.167 mM	6123	
4.3.2.2	5-aminoimidazole-4-carboxamide riboside 5'-monophosphate	i.e. ZMP or AICAR, product inhibition, accumulation in the brain of Lesch-Nyhan disease patients induces inhibition of mitochondrial oxidative phosphorylation and adenylosuccinate lyase activity, followed by dowregulation of ATP levels and multifocal cell death in the cerebellum	147347	
4.3.2.2	8-Aza-AMP	-	29653	
4.3.2.2	adenosine phosphonobutyric acid, 2'(3'),5'-diphosphate	i.e. APBADP, the non-cleavable substrate analogue acts as a competitive inhibitor with respect to either substrate. ASL binds up to 4 mol of APBADP per mole of enzyme tetramer, the enzyme exhibits negative cooperativity. Binding to enzyme mutants, overview	25953	
4.3.2.2	adenosine phosphonobutyric acid, 2'(3'),5'-diphosphate	i.e. APBADP, the non-cleavable substrate analogue acts as a competitive inhibitor with respect to either substrate. ASL binds up to 4 mol of APBADP per mole of enzyme tetramer, the enzyme exhibits positive cooperativity	25953	
4.3.2.2	adenosine phosphonobutyric, 2'(3'), 5'-diposphate	-	97740	
4.3.2.2	adenyloethylphosphonate	-	97739